Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05645406 · ClinicalTrials.gov registry record · Early Phase 1
Estrogen Hormone Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT05645406 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 8 participants.
The verdict
NCT05645406, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose is to determine if the two estradiol products can deliver similar amounts of estradiol after single and multiple dosing.
Interventions
- DRUG Divigel 0.1% Topical Gel
- DRUG Compounded estradiol product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2025-06-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05645406
The ClinicalTrials.gov registry entry for NCT05645406 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Divigel 0.1% Topical Gel is the first listed.
NCT05645406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05645406 about?
NCT05645406 is a clinical study titled "Estrogen Hormone Products". The purpose is to determine if the two estradiol products can deliver similar amounts of estradiol after single and multiple dosing.
What is the current status of trial NCT05645406?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2024-05-14. Estimated completion is 2025-06-15.
What interventions are being tested in trial NCT05645406?
The interventions under investigation include: Divigel 0.1% Topical Gel (DRUG), Compounded estradiol product (DRUG).
Who is sponsoring clinical trial NCT05645406?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.